Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041680 | SCV000065376 | benign | not specified | 2010-12-14 | criteria provided, single submitter | clinical testing | Val3612Val in exon 55 of USH2A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located near a splice junction and is listed in dbSNP (rs61276761, 5/50 Black chromosomes). |
Eurofins Ntd Llc |
RCV000041680 | SCV000231377 | benign | not specified | 2014-09-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000955867 | SCV001102600 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000955867 | SCV001146594 | benign | not provided | 2019-02-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000955867 | SCV001883817 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450741 | SCV004182172 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001273695 | SCV004182173 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000955867 | SCV005287631 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001273695 | SCV001457061 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |